Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guopei Luo

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
International Journal of Molecular Sciences|July 12, 2016
The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic CancerMeng Guo, Guopei Luo, Chen Liu, et al.
Pancreas|March 6, 2020
Prognostic Value and Clinical Predictors of Lymph Node Metastases in Pancreatic Neuroendocrine TumorsZheng Zhang, Mengqi Liu, Shunrong Ji, et al.
International Journal of Biological Sciences|January 9, 2025
Smad2 Cooperating with TGIF2 Contributes to EMT and Cancer Stem Cells Properties in Pancreatic Cancer via Co-Targeting SOX2Fuqiang Zu, ChuanPing Chen, Qilong Geng, et al.
World Journal of Surgical Oncology|September 26, 2022
Carbohydrate antigen 125 supplements carbohydrate antigen 19-9 for the prediction of invasive intraductal papillary mucinous neoplasms of the pancreasYunzhen Qian, Yitao Gong, Guopei Luo, et al.
International Journal of Oncology|August 7, 2014
(18)F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumorsGuopei Luo, Zuqiang Liu, Meng Guo, et al.
Oncogenesis|June 24, 2022
Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinomaYunzhen Qian, Yitao Gong, Xuan Zou, et al.
FEBS Open Bio|November 11, 2017
Distribution of <i>Lewis</i> and <i>Secretor</i> polymorphisms and corresponding CA19-9 antigen expression in a Chinese populationMeng Guo, Guopei Luo, Renquan Lu, et al.
Oncology Letters|March 31, 2017
Patients with normal-range CA19-9 levels represent a distinct subgroup of pancreatic cancer patientsGuopei Luo, Kaizhou Jin, Meng Guo, et al.
Experimental and Therapeutic Medicine|October 23, 2020
Clinical implication of serum CA125 for the prediction of malignancy in mucinous cystic neoplasms of the pancreasShengming Deng, Zhiyao Fan, Yitao Gong, et al.
Journal of Immunology Research|August 1, 2022
Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal AdenocarcinomaYunzhen Qian, Yitao Gong, Yu Liu, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Sciences|July 12, 2016
The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic CancerMeng Guo, Guopei Luo, Chen Liu, et al.
Pancreas|March 6, 2020
Prognostic Value and Clinical Predictors of Lymph Node Metastases in Pancreatic Neuroendocrine TumorsZheng Zhang, Mengqi Liu, Shunrong Ji, et al.
International Journal of Biological Sciences|January 9, 2025
Smad2 Cooperating with TGIF2 Contributes to EMT and Cancer Stem Cells Properties in Pancreatic Cancer via Co-Targeting SOX2Fuqiang Zu, ChuanPing Chen, Qilong Geng, et al.
World Journal of Surgical Oncology|September 26, 2022
Carbohydrate antigen 125 supplements carbohydrate antigen 19-9 for the prediction of invasive intraductal papillary mucinous neoplasms of the pancreasYunzhen Qian, Yitao Gong, Guopei Luo, et al.
International Journal of Oncology|August 7, 2014
(18)F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumorsGuopei Luo, Zuqiang Liu, Meng Guo, et al.
Oncogenesis|June 24, 2022
Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinomaYunzhen Qian, Yitao Gong, Xuan Zou, et al.
FEBS Open Bio|November 11, 2017
Distribution of <i>Lewis</i> and <i>Secretor</i> polymorphisms and corresponding CA19-9 antigen expression in a Chinese populationMeng Guo, Guopei Luo, Renquan Lu, et al.
Oncology Letters|March 31, 2017
Patients with normal-range CA19-9 levels represent a distinct subgroup of pancreatic cancer patientsGuopei Luo, Kaizhou Jin, Meng Guo, et al.
Experimental and Therapeutic Medicine|October 23, 2020
Clinical implication of serum CA125 for the prediction of malignancy in mucinous cystic neoplasms of the pancreasShengming Deng, Zhiyao Fan, Yitao Gong, et al.
Journal of Immunology Research|August 1, 2022
Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal AdenocarcinomaYunzhen Qian, Yitao Gong, Yu Liu, et al.
Pageof 9